Ceribell CEO Chao Xingjuan sells $973,079 in company stock

Ceribell's CEO, Chao Xingjuan, recently sold 39,540 shares of the company's common stock for around $973,079 on September 2, 2026. The transactions occurred near the stock's 52-week high of $25.33, following a 100% gain over the past year, bringing the market capitalization to $943 million. Simultaneously, Xingjuan acquired 25,000 shares through stock options, exercising them at $4.70 per share, totaling about $117,500.

These actions were part of a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025. As a result, Xingjuan now directly owns 767,191 shares of Ceribell common stock. She also indirectly owns 369,088 shares through the ACP 2021 Trust, where she serves as a co-trustee, except for her pecuniary interest. Ceribell reported a 33% increase in second-quarter revenue to $28.1 million for fiscal 2026, despite posting a loss of $0.51 per share.

Analysts like Canaccord and Raymond James have raised their price targets for Ceribell shares, citing growth drivers such as its expansion in seizure-detection business and pediatric care products.